Stereotactic radiotherapy (SIMT FSRT) of brain metastases in a patient with ALK-positive lung adenocarcinoma

Czech version

Authors: L. Hnidáková ¹; P. Pospíšil ¹; J. Garčic ¹; P. Grell ²; R. Belanová ³; L. Hynková ¹; J. Maistryszinová ¹; O. Bílek ²; P. Turčáni ⁴; P. Burkoň ¹; M. Slavik ¹; P. Šlampa ¹; T. Kazda ^1,5
Authors‘ workplace: Klinika radiační onkologie LF MU a MOÚ Brno ¹; Klinika komplexní onkologické péče LF MU a MOÚ Brno ²; Oddělení radiologie, MOÚ Brno ³; Centrum pneumologie a intervenční bronchologie, MOÚ Brno ⁴; RECAMO, MOÚ Brno ⁵
Published in: Klin Onkol 2025; 38(5): 398-400
Category: Case Reports
doi: https://doi.org/10.48095/ccko2025398

Sources

1. Gondi V, Bauman G, Bradfield L et al. Radiation therapy for brain metastases: an ASTRO clinical practice guideline. Pract Radiat Oncol 2022; 12 (4): 265–82. doi: 10.1016/j.prro.2022.02.003.

2. Vogelbaum MA, Brown PD, Messersmith H et al. Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol 2022; 40 (5): 492–516. doi: 10.1200/JCO.21.02314.

3. Le Rhun E, Guckenberger M, Smits M et al. EANO–ESMO clinical practice guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. Ann Oncol 2021; 32 (11): 1332–1347. doi: 10.1016/j.annonc.2021.07.016.

4. Palmer JD, Sebastian NT, Chu J et al. Single-isocenter multitarget stereotactic radiosurgery is safe and effective in the treatment of multiple brain metastases. Adv Radiat Oncol 2020; 5 (1): 70–76. doi: 10.1016/j.adro.2019. 08.013.

5. Kazda T, Jancalek R, Pospisil P et al. Why and how to spare the hippocampus during brain radiotherapy: the developing role of hippocampal avoidance in cranial radiotherapy. Radiat Oncol 2014; 9 (1): 139. doi: 10.1186/1748-717X-9-139.

6. Milano MT, Grimm J, Niemierka A et al. Single -⁠ and multifraction stereotactic radiosurgery dose/volume tolerances of the brain. In J Radiat Oncol Biol Phys 2021; 110 (1): 68–86. doi: 10.1016/j.ijrobp.2020. 08.013.